Four of those cases were due to mutations in the α-synuclein gene (SNCA), one due to the p.G2019S variant in LRRK2, seven due to mutations in one of the AD-causing genes, and one with a pathogenic variant in the β-synuclein gene (SCNB). This evidence concerns the gene SNCA and Alzheimer disease.